A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Catalent, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 12,882 shares of CTLT stock, worth $785,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,882
Previous 13,346 3.48%
Holding current value
$785,544
Previous $750,000 4.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $26,058 - $28,285
-464 Reduced 3.48%
12,882 $780,000
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $715,078 - $760,988
13,346 New
13,346 $750,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.